MedicineWatch US
Class II Recall

Teva Pharmaceuticals USA

Product
Octreotide Acetate Injection 50 mcg/mL, 1 mL single-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3301-01
Reason
Lack of Assurance of Sterility
Classification
Class II
Status
Terminated
Lot
Lot #: 31329169B, 31329231B, exp. Date 06/2022
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Teva Pharmaceuticals USA — Class II Recall | MedicineWatch US